We are live on ! Find out more
VTYX

Ventyx Biosciences
VTYX

Delisted

VTYX was delisted on the 3rd of March, 2026.

Back to rankings

1 hedge funds and large institutions have $21K invested in Ventyx Biosciences in 2026 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 138 closing their positions.

New
Increased
Maintained
Reduced
Closed

73.19% less ownership

Funds ownership: 73.19% → 0% (-73%)

99% less funds holding

Funds holding: 139 → 1 (-138)

99% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 138

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

100% less capital invested

Capital invested by funds: $472M → $21K (-$472M)

Holders
1
Holders Change
-138
Holders Change %
-99.28%
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
138
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
IA
IFP Advisors
Florida
+$20.3K

Top Sellers

Rank Fund Capital Flow
1
AAA
Affinity Asset Advisors
New York
-$58.6M
2
Morgan Stanley
Morgan Stanley
New York
-$38.8M
3
BlackRock
BlackRock
New York
-$28.4M
4
TCM
Tang Capital Management
California
-$25.4M
5
BBA
Baker Bros. Advisors
New York
-$21.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
IA
1
IFP Advisors
Florida
$21K +$20.3K +1,500 New
AAA
2
Affinity Asset Advisors
New York
– -$58.6M -6,484,558 Closed
Morgan Stanley
3
Morgan Stanley
New York
– -$38.8M -4,292,951 Closed
BlackRock
4
BlackRock
New York
– -$28.4M -3,142,440 Closed
TCM
5
Tang Capital Management
California
– -$25.4M -2,814,000 Closed
BBA
6
Baker Bros. Advisors
New York
– -$21.2M -2,349,280 Closed
B
7
Braidwell
Connecticut
– -$17.3M -1,920,255 Closed
D.E. Shaw & Co
8
D.E. Shaw & Co
New York
– -$15M -1,665,474 Closed
MB
9
MPM BioImpact
Massachusetts
– -$14.8M -1,639,061 Closed
Citadel Advisors
10
Citadel Advisors
Florida
– -$14.1M -1,563,611 Closed
Connor, Clark & Lunn Investment Management (CC&L)
11
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
– -$10.9M -1,203,997 Closed
Susquehanna International Group
12
Susquehanna International Group
Pennsylvania
– -$10.1M -1,118,275 Closed
Point72 Asset Management
13
Point72 Asset Management
Connecticut
– -$9.54M -1,056,520 Closed
6CM
14
683 Capital Management
New York
– -$9.39M -1,040,000 Closed
Millennium Management
15
Millennium Management
New York
– -$8.94M -989,917 Closed
IC
16
Ikarian Capital
Texas
– -$8.66M -958,704 Closed
Jane Street
17
Jane Street
New York
– -$8.5M -941,067 Closed
Goldman Sachs
18
Goldman Sachs
New York
– -$7.56M -837,602 Closed
Acadian Asset Management
19
Acadian Asset Management
Massachusetts
– -$6.98M -773,512 Closed
Dimensional Fund Advisors
20
Dimensional Fund Advisors
Texas
– -$6.7M -742,544 Closed
Balyasny Asset Management
21
Balyasny Asset Management
Illinois
– -$6.64M -735,711 Closed
Geode Capital Management
22
Geode Capital Management
Massachusetts
– -$6.53M -722,355 Closed
AGP
23
Artia Global Partners
Florida
– -$6.28M -695,982 Closed
Tudor Investment Corp
24
Tudor Investment Corp
Connecticut
– -$5.27M -583,611 Closed
State Street
25
State Street
Massachusetts
– -$4.96M -548,743 Closed
1
2 3 4 5

VTYX Hedge Fund Activity: Q1 2026 in Review

1 of the 8,127 institutional investors tracked by Wall St. Rank reported a position in Ventyx Biosciences (VTYX) for Q1 2026, worth a combined $21K — down 100% from $472M a quarter earlier.

Sellers outnumbered buyers: 138 funds closed out of VTYX and 1 opened new positions — a net loss of 137 holders — while 0 trimmed existing stakes and 0 added.

The largest buyer was IFP Advisors, opening a new position worth an estimated $20.3K. The largest seller was Affinity Asset Advisors, exiting entirely with an estimated $58.6M sold.

  • 1 institutional investor held Ventyx Biosciences (VTYX) as of Q1 2026, down from 139 in Q4 2025.
  • Funds reported $21K of Ventyx Biosciences stock for Q1 2026, down 100% quarter-over-quarter.
  • 1 fund opened new Ventyx Biosciences positions in Q1 2026 and 138 closed out, a net change of -137 holders.
  • The largest Ventyx Biosciences buyer in Q1 2026 was IFP Advisors, an estimated $20.3K added.
  • The largest Ventyx Biosciences seller in Q1 2026 was Affinity Asset Advisors, an estimated $58.6M sold.

Based on aggregated 13F filings for Q1 2026.